TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Bio-Works Technologies AB
Closing information (x1000 SEK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
43,896
|
41,320
|
21,910 |
Financial expenses |
3
|
23
|
18 |
Earnings before taxes |
-54,734
|
-44,695
|
-9,370 |
EBITDA |
-55,737
|
-45,621
|
-9,135 |
Total assets |
62,152
|
91,613
|
120,861 |
Current assets |
59,663
|
89,180
|
119,077 |
Current liabilities |
18,119
|
23,921
|
12,352 |
Equity capital |
44,033
|
67,692
|
108,509 |
- share capital |
3,898
|
3,518
|
3,487 |
Employees (average) |
39
|
43
|
32 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
70.8%
|
73.9%
|
89.8% |
Turnover per employee |
1,126
|
961
|
685 |
Profit as a percentage of turnover |
-124.7%
|
-108.2%
|
-42.8% |
Return on assets (ROA) |
-88.1%
|
-48.8%
|
-7.7% |
Current ratio |
329.3%
|
372.8%
|
964.0% |
Return on equity (ROE) |
-124.3%
|
-66.0%
|
-8.6% |
Change turnover |
2,576
|
19,410
|
14,676 |
Change turnover % |
6%
|
89%
|
203% |
Chg. No. of employees |
-4
|
11
|
1 |
Chg. No. of employees % |
-9%
|
34%
|
3% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.